Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-045967
Filing Date
2025-05-20
Accepted
2025-05-20 16:14:56
Documents
71
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0242778-10q_regenerative.htm   iXBRL 10-Q 702343
2 CERTIFICATION ea024277801ex31-1_regener.htm EX-31.1 10899
3 CERTIFICATION ea024277801ex31-2_regener.htm EX-31.2 10646
4 CERTIFICATION ea024277801ex32-1_regener.htm EX-32.1 5250
  Complete submission text file 0001213900-25-045967.txt   5191133

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE mssv-20250331.xsd EX-101.SCH 47803
6 XBRL CALCULATION FILE mssv-20250331_cal.xml EX-101.CAL 34354
7 XBRL DEFINITION FILE mssv-20250331_def.xml EX-101.DEF 257636
8 XBRL LABEL FILE mssv-20250331_lab.xml EX-101.LAB 425850
9 XBRL PRESENTATION FILE mssv-20250331_pre.xml EX-101.PRE 272565
74 EXTRACTED XBRL INSTANCE DOCUMENT ea0242778-10q_regenerative_htm.xml XML 494051
Mailing Address 433 PLAZA REAL SUITE 275 BOCA RATON FL 33432
Business Address 433 PLAZA REAL SUITE 275 BOCA RATON FL 33432 800-889-9509
Regenerative Medical Technology Group Inc. (Filer) CIK: 0001760026 (see all company filings)

EIN.: 880492191 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56010 | Film No.: 25968955
SIC: 5990 Retail-Retail Stores, NEC
(CF Office: 07 Trade & Services)